Skip Navigation

A Phase IB/II Study of FT-2102 in Patients with Advanced Solid Tumors and Gliomas with an IDH1 Mutation

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT03684811

Study #:
STUDY00143250

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03684811

View Complete Trial Details & Eligibility at ClinicalTrials.gov